Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Interim Management Statement

21 Jul 2014 07:00

RNS Number : 7841M
Standard Life Euro Pri Eqty Tst PLC
21 July 2014
 

Standard Life European Private Equity Trust PLC

 

Interim management statement for the quarter ended 30 June 2014

 

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 April 2014 to 30 June 2014. This announcement constitutes the Company's second interim management statement for the financial year ending 30 September 2014 in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules. This interim statement summarises information at 30 June 2014 and any material developments up to 18 July 2014.

 

Investment objective

 

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

 

Benchmark

 

The Company has no defined benchmark.

 

Performance

 

The Company's net asset value per ordinary share ("NAV") was 252.2p and its net assets were £401.2 million at 31 March 2014. The Company's NAV at 30 June 2014 will be announced on or around 23 September 2014. The share price of the Company's ordinary shares was 215.0p at 30 June 2014, compared to 204.0p at 31 March 2014, an increase of 5.4% over the quarter.

 

Over the same quarter the MSCI Europe Index (in euros) rose by 2.6% and the FTSE All Share Index (in sterling) rose by 1.3%.

 

Financial position

 

During the quarter ended 30 June 2014 the Company funded £15.3 million of draw downs (six months ended 31 March 2014 - £15.9 million) and received £13.0 million of distributions (six months ended 31 March 2014 - £49.3 million). Draw down activity increased during the quarter as a result of new investment activity by a number of recent fund commitments, notably Permira V where draw downs totalled £5.2 million. While it was a quieter quarter for distributions, the Manager is aware of a number of exits having occurred where the Company is awaiting cash proceeds. As a result of the above, draw downs and distributions for the nine months ended 30 June 2014 were £31.2 million and £62.3 million, respectively.

 

The Company made no new fund commitments in the quarter ended 30 June 2014. The Company had total outstanding commitments to its 42 private equity fund interests of £192.0 million at 30 June 2014 (31 March 2014 - £213.5 million). The Manager continues to believe that up to £40 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2014 the Company had a cash balance, including holdings in money market funds, of £18.1 million and had £22.0 million invested in UK and European equity index tracker funds (31 March 2014 - £22.7 million and £21.9 million, respectively). The Company continues to have an undrawn £80 million syndicated revolving credit facility led by The Royal Bank of Scotland plc that expires in December 2016.

 

 

Directorate changes

 

On 28 May 2014 the Company announced the appointment of Alan Devine to the Board as a non-executive director.

 

Alternative Investment Fund Managers Directive ("AIFMD" or "the Directive")

 

The Company is required to comply with the European Union AIFMD. The Directive requires the Company to appoint an Alternative Investment Fund Manager ("AIFM") who will be responsible for portfolio and risk management and will be regulated under the Directive. The Board has agreed to appoint SL Capital Partners LLP as the AIFM. The Directive also requires the Company to appoint a depositary and the Board has appointed BNP Paribas Securities Services to fulfil this function.

 

Events and transactions in the period to 18 July 2014

 

During the period from 30 June 2014 to 18 July 2014 the Company funded £5.4 million of draw downs and received £15.0 million of distributions. At 18 July 2014 the Company had a cash balance, including holdings in money market funds, of £26.2 million and had £21.6 million invested in UK and European equity index tracker funds.

 

The Company has also made a new commitment of €55.0 million to Altor IV, a Nordic mid-market buy-out fund.Accordingly, at 18 July 2014 the Company had outstanding commitments of £227.9 million.

 

 

For further information on the statement please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the London Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 1158 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUGDRGDBBGSI
Date   Source Headline
12th Feb 20217:00 amRNSEstimated NAV at 31 January 2021
5th Feb 202112:17 pmRNSDoc re. Annual Report
2nd Feb 20215:28 pmRNSDirector/PDMR Shareholding
26th Jan 20217:05 amRNSEstimated NAV at 31 December 2020
26th Jan 20217:00 amRNSAnnual Financial Report
5th Jan 20214:00 pmRNSQuarterly disclosure
22nd Dec 20204:30 pmRNSREPLACEMENT: Dividend Declaration
14th Dec 20203:01 pmRNSEstimated NAV at 30 November
14th Dec 20203:01 pmRNSFourth Interim Dividend
13th Nov 20207:00 amRNSEstimated NAV at 31 October 2020
12th Nov 20203:26 pmRNSDirector/PDMR Shareholding
5th Nov 20208:31 amRNSEdison review on Standard Life Private Equity Trst
3rd Nov 202012:33 pmRNSDirector/PDMR Shareholding
3rd Nov 20207:02 amRNSDirector Declaration
14th Oct 20207:00 amRNSEstimated NAV at 30 September 2020
2nd Oct 20204:28 pmRNSQuarterly disclosure
30th Sep 20207:02 amRNSEstimate Net Asset Value at 31 August 2020
30th Sep 20207:00 amRNSQuarterly Investment Update at 30 June 2020
24th Sep 20207:00 amRNSIncrease of Loan Facility
8th Sep 202012:21 pmRNSEdison review on Standard Life Private Equity Trst
3rd Sep 202011:08 amRNSThird Interim Dividend
14th Aug 20207:00 amRNSEstimated NAV at 31 July 2020
13th Aug 202010:20 amRNSDirector/PDMR Shareholding
6th Aug 20203:04 pmRNSDirector/PDMR Shareholding
15th Jul 20202:10 pmRNSUpdate research from QuotedData
14th Jul 20207:00 amRNSEstimated NAV at 30 June 2020
2nd Jul 20204:43 pmRNSQuarterly disclosure
26th Jun 20207:00 amRNSHalf-Yearly Report
18th Jun 20207:05 amRNSEstimated NAV at 31 May 2020
18th Jun 20207:00 amRNSHalf-year Report
15th May 20207:00 amRNSEstimated Net Asset Value at 30 April 2020
12th May 20204:07 pmRNSHolding(s) in Company
11th May 202012:14 pmRNSGlobal Macro Review – May 2020
28th Apr 20204:20 pmRNSDisclosure of Rights Attaching to Equity Shares
28th Apr 20203:35 pmRNSDirector/PDMR Shareholding
28th Apr 202011:52 amRNSDirector/PDMR Shareholding
24th Apr 20207:02 amRNSEstimated Net Asset Value at 31 March 2020
24th Apr 20207:00 amRNSQuarterly Investment Update at 31 December 2019
3rd Apr 202010:22 amRNSQuarterly Disclosure
13th Mar 20207:00 amRNSMonth End Net Asset Value(s)
11th Mar 20201:59 pmRNSReal Estate Roundup Review – March 2020
9th Mar 20209:52 amRNSDirector Declaration
9th Mar 20207:00 amRNSFirst Interim Dividend
24th Feb 20203:20 pmRNSResult of AGM
14th Feb 20207:00 amRNSMonth End Net Asset Value(s)
13th Feb 202012:37 pmRNSReplacement - Director/PDMR Shareholding
13th Feb 202012:16 pmRNSDirector/PDMR Shareholding
12th Feb 20202:55 pmRNSDirector/PDMR Shareholding
29th Jan 20208:13 amRNSEdison review on Standard Life Private Equity
28th Jan 20204:31 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.